OTC Markets OTCPK USD

Coloplast A/S (CLPBY)

Compare
10.92
-0.05
(-0.46%)
At close: January 14 at 3:58:39 PM EST

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Kristian Villumsen President & CEO 2.2M -- 1970
Mr. Anders Lonning-Skovgaard Executive VP & CFO 1.14M -- 1972
Mr. Allan Rasmussen Executive Vice President of Global Operations 990.68k -- 1967
Mr. Nicolai Buhl Andersen Executive Vice President of Chronic Care 963.16k -- 1969
Mr. Thomas Barfod Senior Controller & Employees Representative Director 61.92k -- 1970
Aleksandra Dimovska Vice President of Investor Relations -- -- --
Mr. Dennis Kaysen Vice President of Corporate Communications -- -- --
Dorthe Ronnau Executive Vice President of People & Culture -- -- 1966
Mr. Alain Morvan Senior Vice President of Sales Europe -- -- --
Ms. Caroline Vagner Rosenstand Executive Vice President of Voice & Respiratory Care -- -- --

Coloplast A/S

Holtedam 1-3
Humlebæk, 3050
Denmark
45 49 11 11 11 https://www.coloplast.com
Sector: 
Healthcare
Full Time Employees: 
16,639

Description

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.

Corporate Governance

Coloplast A/S’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

February 4, 2025 at 6:30 AM UTC

Coloplast A/S Earnings Date

Recent Events

December 20, 2024 at 12:00 AM UTC

Dividend Date

December 9, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers